Welcome to AstraZeneca United States

We push the boundaries of science to deliver life-changing medicines

AZ&You Blog and Articles
 

The Next Horizon in Connected Healthcare – Patient Empowered Virtual Care
Understanding ATTR: The Challenges of Amyloidosis
AstraZeneca’s Aradhana Sarin Named to CNBC’s 2024 Changemakers: Women Transforming Business List

Latest News from AstraZeneca US
 

FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Alexion data at AAN 2024 demonstrate how ULTOMIRIS® and SOLIRIS® can transform outcomes for rare neurological diseases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial

Follow us

Join in the conversation

BioPharmaceuticals

We want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening conditions, achieve remission, and one day cure them.

Learn more

Oncology: Start with One

At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition. But we know that as with every great journey, the road always starts with one—one indication that can change the course of disease for a patient, one person living with cancer that benefits from our support services, one access barrier that we can help to overcome, one system to transform in partnership with the community—and then another, building from there until success is achieved. Click below to read more about this next chapter.

Learn more

What science can do

If you are passionate about science, these stories will show you how the latest and most exciting projects we have been working on and the people behind them.

Explore more on on our global site